Since 2012, SATT Conectus has been detecting inventions that originate in Alsace's public research laboratories and investing financially in their technological development. Our objective: to transfer these innovative technologies to companies in order to industrialize them and launch them on the market.
The innovative technologies supported by Conectus
Developing a new therapy against cancer, countering antibiotic resistance, making a window "smart", developing a new waterproofing treatment, imagining a new detector for pollutants in ambient air, treating the adverse effects of chemotherapies... Each year, some fifteen innovative projects led by Alsatian researchers benefit from a financial investment from Conectus (up to €500k / project) to gain in maturity and become innovative products or services accessible to all on the market.
In which areas does Conectus invest in innovative projects?
Health(1)
Medical technologies
Chemicals / Materials
46%
12%
16%
Engineering(2)
Energy / ecotechnologies
Digital(3)
11%
9%
6%
(1) Therapeutics and diagnosis
(2) Robotics, mechanics, electronics....
(3) Digital, IT....
Results are in!
132
innovative projects supported by Conectus since 2012
42,7 M€
invested by Conectus in innovative projects since 2012
323,5 k€
invested on average per innovative project (year 2017)
142
technology transfers since 2012
35 %
of innovative projects are developed in co-conception
13,6 M€
of revenues from cumulative technology transfers since 2012
229
active intellectual property titles managed
78 %
innovative projects that have benefited companies established in France